Michael Gillogly

Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer

J. Murray, N. Kallinteris, J. Gulfo, 2004, Cancer Immunology, Immunotherapy.

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.

G. Hortobagyi, N. Ibrahim, D. Booser, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Fine Specificity of High Molecular Weight-Melanoma-Associated Antigen-Specific Cytotoxic T Lymphocytes Elicited by Anti-Idiotypic Monoclonal Antibodies in Patients with Melanoma

M. Ross, J. Murray, S. Ferrone, 2004, Cancer Research.

Antibodies in Patients with Melanoma Lymphocytes Elicited by Anti-Idiotypic Monoclonal Weight-Melanoma-Associated Antigen-Specific Cytotoxic T Fine Specificity of High Molecular

M. Ross, J. Murray, S. Ferrone, 2004 .